Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Piotr, Ponikowski,; Veldhuisen, Dirk J, van; Josep, Comin-Colet,; Georg, Ertl,; Michel, Komajda,; Viacheslav, Mareev,; Theresa, McDonagh,; Alexander, Parkhomenko,; Luigi, Tavazzi,; Victoria, Levesque,; Claudio, Mori,; Bernard, Roubert,; Gerasimos, Filippatos,; Frank, Ruschitzka,; Stefan D, Anker,

doi:10.1093/eurheartj/ehu385

Public

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Published in European heart journal • Mar 14, 2015

Authors:

Ponikowski, Piotr

van Veldhuisen, Dirk J

Comin-Colet, Josep

Abstract

AIM: The aim of this study was to evaluate the benefits and safety of long-term i.v. iron therapy in iron-deficient patients with heart failure (HF). METHODS AND RESULTS: CONFIRM-HF was a multi-centre, double-blind, placebo-controlled trial that enrolled 304 ambulatory symptomatic HF patients with l...

Subject

Ferric carboxymaltose

Heart failure

Iron deficiency

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!